Pancreatic Cystic Lesion

2

Review clinical trials related to Pancreatic Cystic Lesion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist endoscopists in the diagnosis of pancreatic cystic lesions(PCLs), mainly differentiating mucinous from non-mucinous lesions. The secondary objective is to evaluate the model's effectiveness in risk stratification and clinical management for patients with PCLs.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Huazhong University of Science and TechnologyUpdated: Mar 11, 2026Locations: 2
Eligibility criteria

Patients whose EUS results indicates pancreatic cystic or cystoid lesions; [+2]

Patients whose age is less than 18 years old; [+6]

Status: Not yet recruiting

Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions

Large prospective comparative observational study in numerous reference centers in France, comparing infectious complications in patients admitted for pancreatic cystic lesions (PCL) aspiration performed with or without antibiotic prophylaxis (ATBp) according to the usual practices. This is a prospective, comparative, observational, multicenter study, with the primary objective of comparing the infection rates in pancreatic cystic lesions (PCL) aspirated under EUS, with and without the administration of ATBp. A sample size of 1702 patients will be needed over a 3-year study period.

Participants needed: 1,702
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Société Française d'Endoscopie DigestiveUpdated: Aug 2, 2024Locations: 1
Eligibility criteria

Patient referred for diagnostic aspiration of a pancreatic cystic lesion [+3]

Patient under 18 years old [+4]